Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
EMD Serono acquires PostEra's fertility programs
PRIVATESep 09, 2026•about 3 hours ago
Acquiring Company
EMD Serono
Acquired Company
PostEra
RocklandBostonBiotechnologyHealth CareMedicalHealth CareScience And Engineering
Description
On September 9, 2026, PostEra announced that EMD Serono, Inc. acquired two of its fertility programs. Following the transaction, EMD Serono will take sole responsibility for their further development and potential worldwide marketing. Both programs are currently in preclinical development and their safety and efficacy in humans have not yet been established.
Company Information
Company
EMD Serono
Location
Rockland, New York, United States
About
EMD Serono - the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada -aspires to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. The business is imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono’s global roots go back more than 350 years with Merck KGaA, Darmstadt, Germany. Today, the business has approximately 1,250 employees around the country with commercial, clinical and research operations in Massachusetts. www.emdserono.com.
Don't miss EMD Serono's next move
Get an email the moment EMD Serono makes an acquisition, hires an exec, or expands, usually minutes after it happens.
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired PostEra?
PostEra was acquired by EMD Serono, based in Rockland. The deal was reported on September 9, 2026. EMD Serono - the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. EMD Serono is privately held and operates in Biotechnology.
When did EMD Serono acquire PostEra?
EMD Serono's acquisition of PostEra was reported on September 9, 2026. On September 9, 2026, PostEra announced that EMD Serono, Inc. acquired two of its fertility programs. Following the transaction, EMD Serono will take sole responsibility for their further development and potential worldwide marketing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PostEra do?
PostEra was founded in 2019 and its technology is built on pioneering academic research done by its founding scientists. PostEra's technology addresses some of the key challenges in drug discovery R&D by integrating molecular design with chemical synthesis. It is privately held, operating in Health Care, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
Rockland